ASPIRA PATHLAB & DIAGNOSTICS | VIJAYA DIAGNOSTIC | ASPIRA PATHLAB & DIAGNOSTICS / VIJAYA DIAGNOSTIC |
|||
---|---|---|---|---|---|
P/E (TTM) | x | -13.4 | 63.8 | - | View Chart |
P/BV | x | 2.6 | 13.4 | 19.1% | View Chart |
Dividend Yield | % | 0.0 | 0.1 | - |
ASPIRA PATHLAB & DIAGNOSTICS VIJAYA DIAGNOSTIC |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
ASPIRA PATHLAB & DIAGNOSTICS Mar-23 |
VIJAYA DIAGNOSTIC Mar-23 |
ASPIRA PATHLAB & DIAGNOSTICS / VIJAYA DIAGNOSTIC |
5-Yr Chart Click to enlarge
|
||
High | Rs | 75 | 527 | 14.2% | |
Low | Rs | 26 | 292 | 8.8% | |
Sales per share (Unadj.) | Rs | 14.0 | 45.0 | 31.2% | |
Earnings per share (Unadj.) | Rs | -0.1 | 8.3 | -1.0% | |
Cash flow per share (Unadj.) | Rs | 1.5 | 14.4 | 10.1% | |
Dividends per share (Unadj.) | Rs | 0 | 1.00 | 0.0% | |
Avg Dividend yield | % | 0 | 0.2 | 0.0% | |
Book value per share (Unadj.) | Rs | 12.4 | 53.2 | 23.3% | |
Shares outstanding (eoy) | m | 10.29 | 102.07 | 10.1% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 3.6 | 9.1 | 39.3% | |
Avg P/E ratio | x | -583.7 | 49.1 | -1,189.2% | |
P/CF ratio (eoy) | x | 34.6 | 28.5 | 121.6% | |
Price / Book Value ratio | x | 4.1 | 7.7 | 52.7% | |
Dividend payout | % | 0 | 12.0 | -0.0% | |
Avg Mkt Cap | Rs m | 518 | 41,821 | 1.2% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 56 | 785 | 7.1% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 145 | 4,592 | 3.1% | |
Other income | Rs m | 3 | 142 | 2.3% | |
Total revenues | Rs m | 148 | 4,734 | 3.1% | |
Gross profit | Rs m | 16 | 1,820 | 0.9% | |
Depreciation | Rs m | 16 | 617 | 2.6% | |
Interest | Rs m | 4 | 209 | 2.0% | |
Profit before tax | Rs m | -1 | 1,135 | -0.1% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 0 | 283 | 0.0% | |
Profit after tax | Rs m | -1 | 852 | -0.1% | |
Gross profit margin | % | 11.0 | 39.6 | 27.8% | |
Effective tax rate | % | 0 | 24.9 | -0.0% | |
Net profit margin | % | -0.6 | 18.6 | -3.3% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 59 | 2,757 | 2.1% | |
Current liabilities | Rs m | 16 | 662 | 2.4% | |
Net working cap to sales | % | 29.5 | 45.6 | 64.8% | |
Current ratio | x | 3.7 | 4.2 | 88.7% | |
Inventory Days | Days | 88 | 125 | 70.4% | |
Debtors Days | Days | 590 | 75 | 782.8% | |
Net fixed assets | Rs m | 115 | 5,695 | 2.0% | |
Share capital | Rs m | 103 | 102 | 100.8% | |
"Free" reserves | Rs m | 25 | 5,326 | 0.5% | |
Net worth | Rs m | 128 | 5,428 | 2.3% | |
Long term debt | Rs m | 10 | 0 | - | |
Total assets | Rs m | 173 | 8,452 | 2.1% | |
Interest coverage | x | 0.8 | 6.4 | 12.3% | |
Debt to equity ratio | x | 0.1 | 0 | - | |
Sales to assets ratio | x | 0.8 | 0.5 | 153.4% | |
Return on assets | % | 1.9 | 12.6 | 15.1% | |
Return on equity | % | -0.7 | 15.7 | -4.4% | |
Return on capital | % | 2.4 | 24.8 | 9.7% | |
Exports to sales | % | 0 | 0 | - | |
Imports to sales | % | 0 | 0 | - | |
Exports (fob) | Rs m | NA | NA | - | |
Imports (cif) | Rs m | NA | NA | - | |
Fx inflow | Rs m | 0 | 0 | - | |
Fx outflow | Rs m | 0 | 2 | 0.0% | |
Net fx | Rs m | 0 | -2 | -0.0% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 0 | 1,646 | -0.0% | |
From Investments | Rs m | 2 | -1,096 | -0.1% | |
From Financial Activity | Rs m | -9 | -419 | 2.2% | |
Net Cashflow | Rs m | -8 | 131 | -6.0% |
Indian Promoters | % | 18.7 | 54.1 | 34.6% | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 0.0 | 40.9 | - | |
FIIs | % | 0.0 | 20.1 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 81.3 | 45.9 | 176.9% | |
Shareholders | 1,512 | 66,724 | 2.3% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare ASPIRA PATHLAB & DIAGNOSTICS With: APOLLO HOSPITALS DR. LAL PATHLABS METROPOLIS HEALTHCARE NARAYANA HRUDAYALAYA KIMS
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | ASPIRA PATHLAB & DIAGNOSTICS | VIJAYA DIAGNOSTIC | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | -2.14% | 1.16% | -0.53% |
1-Month | -8.93% | 7.41% | -0.62% |
1-Year | -3.33% | 86.51% | 52.97% |
3-Year CAGR | 1.86% | 4.58% | 14.71% |
5-Year CAGR | -1.91% | 2.73% | 19.66% |
* Compound Annual Growth Rate
Here are more details on the ASPIRA PATHLAB & DIAGNOSTICS share price and the VIJAYA DIAGNOSTIC share price.
Moving on to shareholding structures...
The promoters of ASPIRA PATHLAB & DIAGNOSTICS hold a 18.7% stake in the company. In case of VIJAYA DIAGNOSTIC the stake stands at 54.1%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of ASPIRA PATHLAB & DIAGNOSTICS and the shareholding pattern of VIJAYA DIAGNOSTIC.
Finally, a word on dividends...
In the most recent financial year, ASPIRA PATHLAB & DIAGNOSTICS paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of -0.0%.
VIJAYA DIAGNOSTIC paid Rs 1.0, and its dividend payout ratio stood at 12.0%.
You may visit here to review the dividend history of ASPIRA PATHLAB & DIAGNOSTICS , and the dividend history of VIJAYA DIAGNOSTIC.
For a sector overview, read our pharmaceuticals sector report.
Asian stocks got off to a positive start on Monday ahead of the Federal Reserve's policy meeting later in the week.